These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1696248)

  • 61. Effect of flecainide on left ventricular ejection fraction.
    Brembilla-Perrot B; Amor M; Auque F; Isaaz K; Terrier de la Chaise A; Bertrand A; Cherrier F; Pernot C
    Eur Heart J; 1987 Jul; 8(7):754-61. PubMed ID: 3115780
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Flecainide acetate for resistant arrhythmias in the young: efficacy and pharmacokinetics.
    Perry JC; McQuinn RL; Smith RT; Gothing C; Fredell P; Garson A
    J Am Coll Cardiol; 1989 Jul; 14(1):185-91; discussion 192-3. PubMed ID: 2500470
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of cardiac arrhythmic risks using a rabbit model of left ventricular systolic dysfunction.
    Hemmeryckx B; Feng Y; Frederix L; Lox M; Trenson S; Vreeken R; Lu HR; Gallacher D; Ni Y; Lijnen HR
    Eur J Pharmacol; 2018 Aug; 832():145-155. PubMed ID: 29782862
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram.
    Lombardi F; Finocchiaro ML; Dalla Vecchia L; Rech R; Castelli A; Pastine J; Cappiello E
    Eur Heart J; 1992 Apr; 13(4):517-25. PubMed ID: 1600992
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.
    Morganroth J; Anderson JL; Gentzkow GD
    J Am Coll Cardiol; 1986 Sep; 8(3):607-15. PubMed ID: 3745706
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Short-term variability of ventricular arrhythmia and rapid assessment of drug efficacy.
    Raeder EA; Hohnloser S; Vlay SC; Olson L
    Am Heart J; 1991 Feb; 121(2 Pt 1):508-11. PubMed ID: 1990755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The Electrocardiographic Footprints of Ventricular Ectopy.
    Mond HG; Haqqani HM
    Heart Lung Circ; 2020 Jul; 29(7):988-999. PubMed ID: 32063472
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Is the morphology of ventricular premature beats a marker for left ventricular dysfunction?
    Angeles K; Betzu R; Gould LA
    N Y State J Med; 1992 Mar; 92(3):89-91. PubMed ID: 1372968
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Usefulness of the intravenous flecainide challenge test before oral flecainide treatment in a patient with Andersen-Tawil syndrome.
    Sato A; Takano T; Chinushi M; Minamino T
    BMJ Case Rep; 2019 Jul; 12(7):. PubMed ID: 31311787
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cardiac arrhythmias during theophylline toxicity. A prospective continuous electrocardiographic study.
    Sessler CN; Cohen MD
    Chest; 1990 Sep; 98(3):672-8. PubMed ID: 2394145
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prevention of arrhythmias after noncardiac thoracic operations: flecainide versus digoxin.
    Borgeat A; Petropoulos P; Cavin R; Biollaz J; Munafo A; Schwander D
    Ann Thorac Surg; 1991 Jun; 51(6):964-7; discussion 967-8. PubMed ID: 1903918
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Ventricular tachyarrhythmias treated with berberine].
    Huang W
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Jun; 18(3):155-6, 190. PubMed ID: 1707782
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The anti-arrhythmic effects of perhexiline maleate in patients with ischaemic heart disease.
    Gitlin N
    S Afr Med J; 1975 Nov; 49(51):2115-7. PubMed ID: 54942
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of sustained-release quinidines given twice daily to patients with ventricular ectopy.
    Lehmann CR; Boran KJ; Kruyer WB; Van Reet RE; Scoville GS; Pierson WP; Melikian AP; Crowe JT; Wright GJ
    J Clin Pharmacol; 1986; 26(8):598-604. PubMed ID: 3793950
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of arrhythmias by flecainide after noncardiac thoracic surgery.
    Borgeat A; Biollaz J; Bayer-Berger M; Kappenberger L; Chapuis G; Chioléro R
    Ann Thorac Surg; 1989 Aug; 48(2):232-4. PubMed ID: 2504119
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The development and testing of intravenous dosing regimens: application to flecainide for the suppression of ventricular arrhythmias.
    Wang T; Siddoway LA; Thompson KA; Conard GJ; Bergstrand RH; Kvam D; Roden DM; Woosley RL
    Clin Pharmacol Ther; 1988 May; 43(5):499-508. PubMed ID: 3130211
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The relationship between frequent and complex ventricular ectopy during 24 h ambulatory electrocardiographic monitoring.
    Messineo FC; Al-Hani AJ; Katz AM
    Cardiology; 1981; 68(2):91-102. PubMed ID: 7273049
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ventricular ectopic activity with spontaneous variant angina: frequency and relation to transient ST segment deviation.
    Gabliani GI; Winniford MD; Fulton KL; Johnson SM; Mauritson DR; Hillis LD
    Am Heart J; 1985 Jul; 110(1 Pt 1):40-3. PubMed ID: 4013988
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Efficacy of propranolol in the control of exercise-induced or augmented ventricular ectopic activity.
    Nixon JV; Pennington W; Ritter W; Shapiro W
    Circulation; 1978 Jan; 57(1):115-22. PubMed ID: 618377
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Evaluation of metoprolol in suppressing complex ventricular arrhythmias.
    Pratt CM; Yepsen SC; Bloom MG; Taylor AA; Young JB; Quinones MA
    Am J Cardiol; 1983 Jul; 52(1):73-8. PubMed ID: 6858932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.